C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
Trial details
- Registry ID
- NCT07037277
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as (BEM/RZR)
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCVNCT07037277 | AVIR | Phase 3 | Active not recruiting | 2026-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |